Mechanisms and clinical implications of the placebo effect: Is there a potential for the elderly? A mini-review

Gerontology

Volumn 57, Issue 4, 2011, Pages 354-363

  Bingel, Ulrike ^a   Colloca, Luana ^c   Vase, Lene ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b AARHUS UNIVERSITY   (Denmark)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Aging; clinical implications; Neurobiology; Nocebo; Placebo; Placebo effect

Indexed keywords

CYCLOSPORIN A; NALOXONE; PLACEBO;

ANALGESIA; ANXIETY DISORDER; BRAIN REGION; CONDITIONING; DEPRESSION; EMOTIONALITY; EXPECTATION; GERIATRIC PATIENT; HUMAN; LIFESPAN; PARKINSON DISEASE; PERSONAL EXPERIENCE; PLACEBO EFFECT; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; VERBAL COMMUNICATION;

AGED; AGED, 80 AND OVER; AGING; BRAIN; COGNITION; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; PLACEBO EFFECT; PLACEBOS;

EID: 79959655977     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000322090     Document Type: Review

References (62)

1. Shapiro AK, Shapiro E: The Powerful Placebo: From Ancient Priest to Modern Physician. Baltimore, Johns Hopkins University Press, 1997.
2. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F: Biological, clinical, and ethical advances of placebo effects. Lancet 2010; 375: 686-695.
3. Beecher HK: The powerful placebo. JAMA 1955; 159:1602-1606.
4. Walsh BT, Seidman SN, Sysko R, Gould M: Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002; 287:1840-1847. (Pubitemid 34303629)
5. Price DD, Finniss DG, Benedetti F: A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 2008; 59: 565-590.
6. Pollo A, Amanzio M, Arslanian A, Casadio C, Maggi G, Benedetti F: Response expectancies in placebo analgesia and their clinical relevance. Pain 2001; 93: 77-84. (Pubitemid 32530845)
7. Hrobjartsson A, Gotzsche PC: Is the placebo powerless? Ananalysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001; 344: 1594-1602. (Pubitemid 32479913)
8. vase L, Riley JL, Price DD: A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 2002; 99: 443-452. (Pubitemid 35284275)
9. vase L, Petersen GL, Riley JL 3rd, Price DD: Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. Pain 2009; 145: 36-44.
10. verne GN, Robinson ME, vase L, Price DD: Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome patients. Pain 2003; 105: 223-230. (Pubitemid 37173409)
11. vase L, Robinson ME, verne GN, Price DD: Increased placebo analgesia over time in irritable bowel syndrome patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 2005; 115: 338-347. (Pubitemid 40725290)
12. voudouris NJ, Peck CL, Coleman G: Conditioned response models of placebo phenomena: further support. Pain 1989; 38:109-116. (Pubitemid 19184846)
13. Montgomery GH, Kirsch I: Classical conditioning and the placebo effect. Pain 1997; 72: 107-113. (Pubitemid 27321908)
14. Klinger R, Soost S, Flor H, Worm M: Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin. Pain 2007; 128:31-39. (Pubitemid 46216597)
15. De Pascalis v, Chiaradia C, Carotenuto E: The contribution of suggestibility and expectation to placebo analgesia phenomenon in an experimental setting. Pain 2002; 96: 393-402. (Pubitemid 34327888)
16. vase L, Robinson ME, verne GN, Price DD: The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain 2003; 105:17-25. (Pubitemid 37162469)
17. Colloca L, Sigaudo M, Benedetti F: The role of learning in nocebo and placebo effects. Pain 2008; 136: 211-218.
18. Colloca L, Benedetti F: How prior experience shapes placebo analgesia. Pain 2006; 124: 126-133. (Pubitemid 44176203)
19. Amanzio M, Benedetti F: Neuropharmaco-logical dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 1999; 19: 484-494. (Pubitemid 29028987)
20. Benedetti F, Pollo A, Lopiano L, Lanotte M, vighetti S, Rainero I: Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 2003; 23: 4315-4323. (Pubitemid 36958452)
21. Goebel MU, Trebst AE, Steiner J, Xie YF, Exton MS, Frede S, Canbay AE, Michel MC, Heemann U, Schedlowski M: Behavioral conditioning of immunosuppression is possible in humans. FASEB J 2002; 16: 1869-1873. (Pubitemid 35462605)
22. Colloca L, Benedetti F: Placebo analgesia induced by social observational learning. Pain 2009; 144:28-34.
23. Flaten MA, Aslaksen PM, Finset A, Simonsen T, Johansen O: Cognitive and emotional factors in placebo analgesia. J Psychosom Res 2006; 61: 81-89. (Pubitemid 43927853)
24. Klosterhalfen S, Kellermann S, Braun S, Kowalski A, Schrauth M, Zipfel S, Enck P: Gender and the nocebo response following conditioning and expectancy. J Psychosom Res 2009; 66:323-328.
25. Geers AL, Kosbab K, Helfer SG, Weiland PE, Wellman JA: Further evidence for individual differences in placebo responding: an inter-actionist perspective. J Psychosom Res 2007; 62: 563-570. (Pubitemid 46635471)
26. Morton DL, Watson A, El-Deredy W, Jones AK: Reproducibility of placebo analgesia: effect of dispositional optimism. Pain 2009; 146: 194-198.
27. Levine JD, Gordon NC, Jones RT, Fields HL: The narcotic antagonist naloxone enhances clinical pain. Nature 1978; 272: 826-827. (Pubitemid 8316990)
28. Petrovic P, Kalso E, Petersson KM, Ingvar M: Placebo and opioid analgesia - imaging a shared neuronal network. Science 2002; 295: 1737-1740. (Pubitemid 34202913)
29. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD: Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 2004; 303: 1162-1167. (Pubitemid 38233575)
30. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, Buchel C: Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009; 63: 533-543.
31. Bingel U, Lorenz J, Schoell E, Weiller C, Buchel C: Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 2006; 120:8-15. (Pubitemid 43078587)
32. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, Nichols TE, Stohler CS: Placebo effects mediated by endogenous opioid activity on μ-opioid receptors. J Neurosci 2005; 25:7754-7762. (Pubitemid 41208646)
33. Levine JD, Gordon NC, Fields HL: The mechanism of placebo analgesia. Lancet 1978; 2:654-657. (Pubitemid 9048375)
34. Krummenacher P, Candia v, Folkers G, Schedlowski M, Schonbachler G: Prefrontal cortex modulates placebo analgesia. Pain 2010; 148:368-374.
35. Benedetti F, Arduino C, Costa S, vighetti S, Tarenzi L, Rainero I, Asteggiano G: Loss of expectation-related mechanisms in Alz heimer's disease makes analgesic therapies less effective. Pain 2006; 121: 133-144. (Pubitemid 43261640)
36. Petrovic P, Kalso E, Petersson KM, Ingvar M: Placebo and opioid analgesia - imaging a shared neuronal network. Science 2002; 295: 1737-1740. (Pubitemid 34202913)
37. Price DD, Craggs J, verne GN, Perlstein WM, Robinson ME: Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 2007; 127:63-72. (Pubitemid 44959430)
38. Eippert F, Finsterbusch J, Bingel U, Buchel C: Direct evidence for spinal cord involvement in placebo analgesia. Science 2009; 326: 404.
39. Fields H: State-dependent opioid control of pain. Nat Rev Neurosci 2004; 5: 565-575. (Pubitemid 38868552)
40. Petrovic P, Dietrich T, Fransson P, Andersson J, Carlsson K, Ingvar M: Placebo in emotional processing-induced expectations of anxiety relief activate a generalized modulatory network. Neuron 2005; 46: 957-969. (Pubitemid 40805354)
41. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, Jerabek PA: The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002; 159:728-737. (Pubitemid 34465045)
42. Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M: Changes in brain fu nction of depressed subjects during treatment with placebo. Am J Psychiatry 2002; 159:122-129. (Pubitemid 41070737)
43. Furmark T, Appel L, Henningsson S, Ahs F, Faria v, Linnman C, Pissiota A, Frans O, Bani M, Bettica P, Pich EM, Jacobsson E, Wahlstedt K, Oreland L, Langstrom B, Eriksson E, Fredrikson M: A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci 2008; 28: 13066-13074.
44. Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE: Monoamine oxidase and catechol-O-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psycho-pharmacol 2009; 29: 372-377.
45. de la Fuente-Fernández R, Ruth TJ, Sossi v, Schulzer M, Calne DB, Stoessl AJ: Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 2001; 293:1164-1166. (Pubitemid 32758101)
46. Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, Bergamasco B, Lopiano L: Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci 2004; 7: 587-588. (Pubitemid 38691896)
47. Benedetti F, Lanotte M, Colloca L, Ducati A, Zibetti M, Lopiano L: Electrophysiological properties of thalamic, subthalamic and ni-gral neurons during the anti-parkinsonian placebo response. J Physiol 2009; 587: 3869-3883.
48. Schweinhardt P, Seminowicz DA, Jaeger E, Duncan GH, Bushnell MC: The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. J Neurosci 2009; 29:4882-4887.
49. Levine JD, Gordon NC: Influence of the method of drug administration on analgesic response. Nature 1984; 312:755-756. (Pubitemid 15195921)
50. Amanzio M, Pollo A, Maggi G, Benedetti F: Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain 2001; 90:205-215. (Pubitemid 32162942)
51. Colloca L, Lopiano L, Lanotte M, Benedetti F: Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol 2004; 3:679-684. (Pubitemid 39370638)
52. Lyerly SB, Ross S, Krugman AD, Clyde DJ: Drugs and placebos: the effects of instructions upon performance and mood under amphetamine sulphate and chloral hydrate. J Abnorm Psychol 1964; 68:321-327.
53. Ulrich RS: view through a window may influence recovery from surgery. Science 1984; 224:420-421. (Pubitemid 14134006)
54. Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, Kirsch I, Schyner RN, Nam BH, Nguyen LT, Park M, Rivers AL, McManus C, Kokkotou E, Drossman DA, Goldman P, Lembo AJ: Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008; 336: 999-1003. (Pubitemid 351656091)
55. Barsky AJ, Saintfort R, Rogers MP, Borus JF: Nonspecific medication side effects and the nocebo phenomenon. JAMA 2002; 287: 622-627. (Pubitemid 34252015)
56. Rief W, Nestoriuc Y, von Lilienfeld-Toal A, Dogan I, Schreiber F, Hofmann SG, Barsky AJ, Avorn J: Differences in adverse effect reporting in placebo groups in SSRI and tricy-clic antidepressant trials: a systematic review and meta-analysis. Drug Saf 2009; 32:1041-1056.
57. Amanzio M, Corazzini LL, vase L, Benedetti F: A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain 2009; 146: 261-269.
58. Bodenheimer T: The future of primary care: transforming practice. N Engl J Med 2008; 359: 2086, 2089.
59. Conboy LA, Macklin E, Kelley J, Kokkotou E, Lembo A, Kaptchuk T: Which patients improve: characteristics increasing sensitivity to a supportive patient-practitioner relationship. Soc Sci Med 2010; 70:479-484.
60. Sneed JR, Rutherford BR, Rindskopf D, Lane DT, Sackeim HA, Roose SP: Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry 2008; 16:65-73.
61. Edwards RR, Bingham CO 3rd, Bathon J, Haythornthwaite JA: Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis Rheum 2006; 55:325-332.
62. Colloca L, Benedetti F, Porro CA: Experimental designs and brain mapping approaches for studying the placebo analgesic effect. Eur J Appl Physiol 2008; 102:371-380.